Status:
COMPLETED
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs
Lead Sponsor:
E-DA Hospital
Conditions:
Tuberculosis
Eligibility:
All Genders
18+ years
Brief Summary
The fixed-dose combinations (FDC) with two or more antituberculous drugs in one capsule or tablet are available to prevent the development of drug resistance. However, the fixed-dose combination regim...
Eligibility Criteria
Inclusion
- Newly diagnosed pulmonary TB and extrapulmonary TB patients
- No previous anti-TB drugs treatment
- Age≥18years old
Exclusion
- Expected life \< 6months
- Baseline AST/ALT \> 3x upper limit of normal (ULN)
- Age \<18years old
Key Trial Info
Start Date :
October 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT00979290
Start Date
October 1 2008
End Date
November 1 2011
Last Update
April 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
E-DA hospital
Kaohsiung City, Taiwan